作者:
Maio,M. [1]
;
Danielli,R. [2]
;
Chiarion-Sileni,V. [3]
;
Pigozzo,J. [4]
;
Parmiani,G. [5]
;
Ridolfi,R. [6]
;
DeRosa,F. [7]
;
DelVecchio,M. [8]
;
DiGuardo,L. [9]
;
Queirolo,P. [10]
;
Picasso,V. [11]
;
Marchetti,P. ;
DeGalitiis,F. ;
Mandalà,M. ;
Guida,M. ;
Simeone,E. ;
Ascierto,P.A.
作者单位:
Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna for the Study
[1]
Medical Oncology Unit A, San Martino Hospital, National Institute for Cancer Research, Genoa, Italy
[2]
Unit of Immuno-Biotherapy of Melanoma and Solid Tumors, San Raffaele Hospital, Milan, Italy
[3]
Department of Immuno-oncodermatology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome
[4]
Melanoma Cancer Unit, Veneto Oncology Institute-IRCCS, Padua, Italy
[5]
Unit of Medical Oncology, Bergamo Hospital, Bergamo, Italy
[6]
Medical Oncology Department, National Cancer Research Centre, 'Giovanni Paolo II' Cancer Institute
[7]
Department of Immuno-oncodermatology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy
[8]
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
[9]
Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Tuscan
[10]
Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione
[11]
发布时间
2014-01-21